Get the Stockscreener App
1.67
5.65%
-0.10
After Hours:
1.67
Cibus Inc stock is traded at $1.67, with a volume of 212.78K.
It is down -5.65% in the last 24 hours and down -6.70% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.77
Open:
$1.78
24h Volume:
212.78K
Relative Volume:
0.68
Market Cap:
$127.64M
Revenue:
$4.29M
Net Income/Loss:
$-104.03M
P/E Ratio:
-0.8484
EPS:
-1.9685
Net Cash Flow:
$-50.65M
1W Performance:
-12.57%
1M Performance:
-6.70%
6M Performance:
-48.77%
1Y Performance:
+18.44%
1-Day Range:
$1.6401
$1.78
1-Week Range:
$1.5316
$2.07
52-Week Range:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.67 | 135.28M | 4.29M | -104.03M | -50.65M | -1.9685 |
VRTX
Vertex Pharmaceuticals Inc
|
515.55 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.93 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
987.84 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
212.00 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.51 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report - Yahoo Finance
HC Wainwright Issues Pessimistic Forecast for Cibus Earnings - MarketBeat
Cibus Is Trying To Turn Gene-Edited Traits Into Royalties - Finimize
Teleconferência de Resultados do 2T26 da Cibus (CBUS): Lançamento do Arroz Passa para 2028 com Queda de Custos - TradingKey
Conferencia de resultados del T2 de 2026 de Cibus (CBUS): El lanzamiento del arroz se traslada a 2028 a medida que disminuyen los costos - TradingKey
Cibus (CBUS) Q2 2026 Earnings Call: Rice Launch Moves to 2028 as Costs Decline - TradingKey
Cibus Inc (CBUS) (Q2 2026) Earnings Call Highlights: Strategic P - GuruFocus
CBUS Looks 4.7% Undervalued on GF Value™ - GuruFocus
Cibus (NASDAQ:CBUS) Releases Earnings Results - MarketBeat
Cibus Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Cibus Q2 2026 revenue miss sparks 16% after-hours drop - Investing.com
Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Cibus Q2 Results: Revenue rises 11% YoY, cash usage drops 31% - scanx.trade
Cibus Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cibus: Q2 Earnings Snapshot - marketscreener.com
Cibus (CBUS) cuts costs but warns on going concern amid Q2 2026 loss - Stock Titan
Q2 2026 Cibus Inc Earnings Call Transcript - GuruFocus
Cibus (CBUS) narrows Q2 2026 loss as cash burn falls and regulatory tailwinds build - Stock Titan
Cibus Reports Second Quarter Financial Results and Provides Business Update - The Manila Times
Earnings To Watch: Cibus Inc (CBUS) Q2 2026 -- GF Value Sees 14% Downside - Yahoo Finance
Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call - 富途牛牛
Cibus Inc (CBUS) Stock News Today - TradingKey
Cibus Inc (CBUS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CBUS Q2'26 Earnings: revenue estimate is 1.70M USD - TradingView
Cibus (CBUS) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Cibus Inc. (CBUS) Steadies at $1.93: Consolidation Between $1.83 Support and $2.03 ResistanceRetail Driven Moves - dars.gov.et
Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close ... - Caledonian Record
Cibus to Report Second Quarter 2026 Financial Results on - GlobeNewswire
Cibus helps farmers grow more food with fewer inputs; Aug. 13 webcast - Stock Titan
Cibus Inc. (CBUS) Gains 7.18% as Stock Approaches Key Resistance LevelTRIN Signal - dars.gov.et
Cibus Market Sentiment - Benzinga
Cibus Inc (CBUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
888,124 Shares in Cibus, Inc. $CBUS Bought by Weiss Asset Management LP - MarketBeat
Cibus Inc (CBUS) Cash Flow - TradingKey
Cibus Inc (CBUS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cibus Inc (CBUS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CBUS|Cibus Inc|Price:1.700|Chg%:-0.080 - TradingKey
Cibus, Inc. Revenue Breakdown – NASDAQ:CBUS - TradingView
TradingKey - TradingKey
Cibus (NASDAQ:CBUS) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
CBUS|Cibus Inc|Price:1.690|Chg%:-0.090 - TradingKey
Cibus Inc (CBUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cibus Inc (CBUS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CBUS|Cibus Inc|Price:1.800|Chg%:-0.010 - TradingKey
CBUS|Cibus Inc|Price:1.800|Chg%:+0.100 - TradingKey
Cibus Inc (CBUS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CBUS Q1 2026 Earnings: EPS Beats Estimates Despite Revenue AbsenceEarnings Weakness Phase - dars.gov.et
Cibus (NASDAQ:CBUS) Trading 5.7% HigherHere's Why - MarketBeat
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection - Yahoo Finance
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report - Yahoo Finance
Cibus Inc. (CBUS) Surges Over 12% as Momentum Builds at Key LevelsGrowth Stock Picks - dars.gov.et
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.80%
1.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):